Literature DB >> 30813783

Locally recurrent chondrosarcoma of the pelvis and limbs can only be controlled by wide local excision.

M K Laitinen1, M C Parry2, L-R Le Nail3, C H Wigley4, J D Stevenson2, L M Jeys4.   

Abstract

AIMS: The purpose of this study was to investigate the potential for achieving local and systemic control after local recurrence of a chondrosarcoma of bone. PATIENTS AND METHODS: A total of 126 patients with local recurrence (LR) of chondrosarcoma (CS) of the pelvis or a limb bone were identified from a prospectively maintained database, between 1990 and 2015 at the Royal Orthopaedic Hospital, Birmingham, United Kingdom. There were 44 female patients (35%) and 82 male patients (65%) with a mean age at the time of LR of 56 years (13 to 96). The 126 patients represented 24.3% of the total number of patients with a primary CS (519) who had been treated during this period. Clinical data collected at the time of primary tumour and LR included the site (appendicular, extremity, or pelvis); primary and LR tumour size (in centimetres); type of operation at the time of primary or LR (limb-salvage or amputation); surgical margin achieved at resection of the primary tumour and the LR; grade of the primary tumour and the LR; gender; age; and oncological outcomes, including local recurrence-free survival and disease-specific survival. A minimum two years' follow-up and complete histopathology records were available for all patients included in the study.
RESULTS: For patients without metastases prior to or at the time of local recurrence, the disease-specific survival after local recurrence was 62.5% and 45.5% at one and five years, respectively. After univariable analysis, significant factors predicting disease-specific survival were grade (p < 0.001) and surgical margin (p = 0.044). After multivariable analysis, grade, increasing age at the time of diagnosis of local recurrence, and a greater time interval from primary surgery to local recurrence were significant factors for disease-specific survival. A secondary local recurrence was seen in 26% of patients. Wide margins were a good predictor of local recurrence-free survival for subsequent recurrences after univariable analysis when compared with intralesional margins (p = 0.002) but marginal margins did not reach statistical significance when compared with intralesional margins (p = 0.084).
CONCLUSION: In cases of local recurrence of a chondrosarcoma of bone, we have shown that if the tumour is non-metastatic at re-staging, an increase in disease-specific survival and in local recurrence-free survival is achievable, but only by resection of the local recurrence with a wide margin. Cite this article: Bone Joint J 2019;101-B:266-271.

Entities:  

Keywords:  Bone neoplasms; Chondrosarcoma; Margins of excision; Neoplasm recurrence

Mesh:

Year:  2019        PMID: 30813783     DOI: 10.1302/0301-620X.101B3.BJJ-2018-0881.R1

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  12 in total

1.  Factors, treatments, and outcomes associated with primary soft tissue malignancies of the forearm: A series of 31 cases.

Authors:  John Heer; Daniel C Allison; Christopher S Helmstedter
Journal:  J Orthop       Date:  2021-11-11

2.  The influence of site on the incidence and diagnosis of solitary central cartilage tumours of the femur. A 21st century perspective.

Authors:  A M Davies; A Patel; C Azzopardi; S L James; R Botchu; L Jeys
Journal:  J Clin Orthop Trauma       Date:  2022-07-30

Review 3.  Surgical Treatment of Bone Sarcoma.

Authors:  Felix Bläsius; Heide Delbrück; Frank Hildebrand; Ulf Krister Hofmann
Journal:  Cancers (Basel)       Date:  2022-05-29       Impact factor: 6.575

4.  Clinical Characteristics, Prognostic Factor and a Novel Dynamic Prediction Model for Overall Survival of Elderly Patients With Chondrosarcoma: A Population-Based Study.

Authors:  Yuexin Tong; Yuekai Cui; Liming Jiang; Yangwei Pi; Yan Gong; Dongxu Zhao
Journal:  Front Public Health       Date:  2022-06-30

5.  Shikonin derivatives cause apoptosis and cell cycle arrest in human chondrosarcoma cells via death receptors and MAPK regulation.

Authors:  Birgit Lohberger; Dietmar Glänzer; Heike Kaltenegger; Nicole Eck; Andreas Leithner; Rudolf Bauer; Nadine Kretschmer; Bibiane Steinecker-Frohnwieser
Journal:  BMC Cancer       Date:  2022-07-12       Impact factor: 4.638

Review 6.  Percutaneous biopsy of musculoskeletal tumors and the potential for needle tract seeding: technical considerations, current controversies, and outcomes.

Authors:  Cara Lai; Jeremiah R Long; Brandon T Larsen; Jose M Iturregui; Benjamin K Wilke; Krista A Goulding
Journal:  Skeletal Radiol       Date:  2022-10-18       Impact factor: 2.128

7.  The changing face of central chondrosarcoma of bone. One UK-based orthopaedic oncology unit's experience of 33 years referrals.

Authors:  A Mark Davies; Anish Patel; Rajesh Botchu; Christine Azzopardi; Steven James; Lee Jeys
Journal:  J Clin Orthop Trauma       Date:  2021-02-27

8.  Prognostic nomograms to predict overall survival and cancer-specific survival in patients with pelvic chondrosarcoma.

Authors:  Li Chen; Cheng Long; Jiaxin Liu; Xin Duan; Zhou Xiang
Journal:  Cancer Med       Date:  2019-07-29       Impact factor: 4.452

9.  Evaluation of prognostic factors affecting survival in chondrosarcoma treatment and comparison with literature.

Authors:  Hüseyin Sina Coşkun; Furkan Erdoğan; İsmail Büyükceran; Nevzat Dabak
Journal:  Jt Dis Relat Surg       Date:  2022-07-06

Review 10.  Chondrosarcoma-from Molecular Pathology to Novel Therapies.

Authors:  Agnieszka E Zając; Sylwia Kopeć; Bartłomiej Szostakowski; Mateusz J Spałek; Michał Fiedorowicz; Elżbieta Bylina; Paulina Filipowicz; Anna Szumera-Ciećkiewicz; Andrzej Tysarowski; Anna M Czarnecka; Piotr Rutkowski
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.